Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
The Hemp Tea Company, LLC manages a patent portfolio in the Biotechnology & Pharmaceuticals technology area. There is 1 pending office action currently active for this portfolio. This action is assigned to 1 distinct art unit. The focus on Biotechnology & Pharmaceuticals suggests that the company's current intellectual property efforts are concentrated on biological or medicinal products related to its core business.
Prosecution for the company involves a distinct examiner. MI, QIUWEN is identified as the busiest examiner for the portfolio. This examiner is responsible for the pending office action. The concentration of the pending workload under one examiner and one art unit indicates a streamlined examination process for the company's current filings. This structure allows the applicant to engage directly with MI, QIUWEN, which can lead to a more consistent and efficient examination process for the 1 pending office action. The involvement of a single distinct examiner ensures that the prosecution strategy remains focused within the Biotechnology & Pharmaceuticals field.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 only | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| MI, QIUWEN | 1 | 68.4% | +49.9% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18534272 | EDIBLE CANNABIS PLANT POWDER | MI, QIUWEN | 72d |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18534272 | EDIBLE CANNABIS PLANT POWDER | MI, QIUWEN | 72d |
| Art Unit | Apps |
|---|---|
| 1655 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18534272 | EDIBLE CANNABIS PLANT POWDER | MI, QIUWEN | 1655 | §101 | Non-Final OA | 72d | Pending | Dec 08, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial